Kristine A Isanogle Selected Research

Ewing Sarcoma (Sarcoma, Ewing)

4/2024

Enhancing standard of care chemotherapy efficacy using DNA-dependent protein kinase (DNA-PK) inhibition in preclinical models of Ewing sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristine A Isanogle Research Topics

Disease

4	Neoplasms (Cancer) 04/2024 - 01/2018
3	Rhabdomyosarcoma 01/2023 - 01/2018
1	Ewing Sarcoma (Sarcoma, Ewing) 04/2024
1	Neuroblastoma 01/2021

Drug/Important Bio-Agent (IBA)

3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2018
3	trametinibIBA 01/2023 - 01/2018
1	AZD7648IBA 04/2024
1	DNA (Deoxyribonucleic Acid)IBA 04/2024
1	Etoposide (VP 16)FDA LinkGeneric 04/2024
1	DNA-Activated Protein KinaseIBA 04/2024
1	Phosphotransferases (Kinase)IBA 01/2023
1	ganitumabIBA 01/2023
1	Vinca AlkaloidsIBA 01/2021
1	ON 01910IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 04/2024
1	Therapeutics 01/2021
1	Treatment Delay 01/2021